Hospital or health organisation · founded 1981
Moffitt Cancer Center
Tampa, United States · moffitt.org
- Citations, last 5 years
- 134.7k
- Works, last 5 years
- 13.7k
- h-index
- 815
- Scientists listed
- 950
- Grants since 2016
- 1 073
Grants received
2016–2028 · cooperative agreement · U01
Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center
John J Heine · Moffitt Cancer Center · funded by National Institutes of Health
2016–2023 · cooperative agreement · U01
Moffitt Imaging Biomarker VAlidation Center
Robert J. Gillies · Moffitt Cancer Center · funded by National Institutes of Health
2016–2024 · cooperative agreement · UH3
Validation of EGFR Protein Complexes as Molecular Diagnostics
Eric B. Haura · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · career development · K08
Epigenetic Modulation of Immune Tolerance by Ionizing Radiation and Chemotherapy
Sungjune Kim · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-language RCT
Thomas H Brandon · Moffitt Cancer Center · funded by National Institutes of Health
2016–2023 · research · R01
Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-language RCT
Vani N Simmons · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · cooperative agreement · U01
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer
David Basanta Gutierrez · Moffitt Cancer Center · funded by National Institutes of Health
2016–2020 · contract · N01
IGF::OT::IGF - Production Assistance for Cellular Therapies (PACT)- Cell Processing Facilities
Linda Kelley · Moffitt Cancer Center · funded by National Institutes of Health
2016–2019 · cooperative agreement · UH2
Validation of EGFR Protein Complexes as Molecular Diagnostics
Eric B. Haura · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · cooperative agreement · U01
Moffitt Imaging Biomarker VAlidation Center
Robert J. Gillies · Moffitt Cancer Center · funded by National Institutes of Health
2016–2018 · cooperative agreement · UH2
Crowdsourcing optimal cancer treatment strategies that maximize efficacy and minimize toxicity
Alexander Robertson Allan Anderson · Moffitt Cancer Center · funded by National Institutes of Health
2016–2023 · research · R35
Targeting Mutant KRAS for Cancer Therapy
Said M Sebti · Moffitt Cancer Center · funded by National Institutes of Health
2016–2019 · career development · K22
BACH2 in Melanoma Development and Resistance
Florian Karreth · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-language RCT
Thomas H Brandon · Moffitt Cancer Center · funded by National Institutes of Health
2016–2023 · research · R35
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
Elsa R Flores · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Epidemiology and biology of lncRNAs in ovarian cancer
Simon Andrew Gayther · Moffitt Cancer Center · funded by National Institutes of Health
2016–2023 · research · R35
Targeting Mutant KRAS for Cancer Therapy
Said M Sebti · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Expanding the Reach of a Validated Smoking-Cessation Intervention: A Spanish-language RCT
Thomas H Brandon · Moffitt Cancer Center · funded by National Institutes of Health
2016–2019 · research · R01
Development of in vivo active small molecule selective inhibitors of ASK1
Thomas D Bannister · Moffitt Cancer Center · funded by National Institutes of Health
2016–2023 · research · R35
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
Elsa R Flores · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Epidemiology and biology of lncRNAs in ovarian cancer
Simon Andrew Gayther · Moffitt Cancer Center · funded by National Institutes of Health
2016–2017 · research · R21
Inhibition of the CMG Helicase as Novel Anti-Neoplastic Approach
Mark G. Alexandrow · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · cooperative agreement · U01
Moffitt Imaging Biomarker VAlidation Center
Robert J. Gillies · Moffitt Cancer Center · funded by National Institutes of Health
2016–2018 · research · R00
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
Lixin Wan · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
Epidemiology and biology of lncRNAs in ovarian cancer
Simon Andrew Gayther · Moffitt Cancer Center · funded by National Institutes of Health
2016–2020 · career development · K01
Developing a Culturally Targeted mHealth Intervention for Cancer-Related Sleep Disturbance in African American Breast Cancer Survivors
Brian D Gonzalez · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · career development · K08
Epigenetic Modulation of Immune Tolerance by Ionizing Radiation and Chemotherapy
Sungjune Kim · Moffitt Cancer Center · funded by National Institutes of Health
2016–2023 · cooperative agreement · U01
Moffitt Imaging Biomarker VAlidation Center
Robert J. Gillies · Moffitt Cancer Center · funded by National Institutes of Health
2016–2019 · research · R01
(PQA4) Molecularly Targeted Chemoprevention for Preneoplastic Squamous (5R01 CA194617-02)
Kenneth Y Tsai · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · career development · K08
Epigenetic Modulation of Immune Tolerance by Ionizing Radiation and Chemotherapy
Sungjune Kim · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · cooperative agreement · U01
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer
David Basanta Gutierrez · Moffitt Cancer Center · funded by National Institutes of Health
2016–2021 · research · R01
MicroRNA Targets for Chemoprevention of Squamous Cell Carcinoma (R01 CA194062-01A1)
Kenneth Y Tsai · Moffitt Cancer Center · funded by National Institutes of Health
2016–2022 · research · R01
Epidemiology and biology of lncRNAs in ovarian cancer
Simon Andrew Gayther · Moffitt Cancer Center · funded by National Institutes of Health
2016–2019 · research · R21
New approaches to target protein intramolecular interactions
Jiandong Chen · Moffitt Cancer Center · funded by National Institutes of Health
2016–2019 · research · R01
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
Scott J. Antonia · Moffitt Cancer Center · funded by National Institutes of Health
2016–2023 · research · R35
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
Elsa R Flores · Moffitt Cancer Center · funded by National Institutes of Health
2016–2017 · research · R03
Refining and testing the electronic Social Network Assessment Program (eSNAP)
Maija Reblin · Moffitt Cancer Center · funded by National Institutes of Health
2016–2019 · research · R01
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
Scott J. Antonia · Moffitt Cancer Center · funded by National Institutes of Health
2016–2023 · research · R35
Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma
Elsa R Flores · Moffitt Cancer Center · funded by National Institutes of Health
2016–2019 · research · R01
Targeting the adenosine A2A receptor immune checkpoint in lung cancer patients
Scott J. Antonia · Moffitt Cancer Center · funded by National Institutes of Health